New COVID hybrid XE could be the most transmissible yet, WHO says
A new COVID hybrid first detected in the UK could be 10% more transmissible than the BA.2 sub-variant of Omicron, the World Health Organization (WHO) has said.
There have been a total of 637 cases of XE – a recombinant of Omicron BA.1 and BA.2 – in the UK so far, according to UK Health Security Agency (UKHSA).
XE Variant: New COVID Strain May be More Contagious Than BA.2 Subvariant, WHO Says
The more contagious omicron subvariant BA.2 has become the dominant COVID-19 strain in the U.S., but international health experts are putting an increased focus on a new hybrid variant that may even be more infectious.
The XE variant is a recombinant, meaning it is comprised of genetic material from two other strains, which in this case are BA.1, the original strain of omicron, and BA.2, known as "stealth omicron."
According to an epidemiological update published March 29 by the World Health Organization, estimates show XE is 10% more transmissible than BA.2, however the findings require further confirmation.
@Anxious most IB analyst forecast gloves to be neutral. While glove counters are cheap, I don't expect price to move up anytime soon. We just have to rely on decent QR results or other external factors to push price up. My glove counters are safely tuck in the freezer, paying more attention to other industries.
@Anxious, bang_miskin is bang on. Just hang on to gloves for now and come back on major macro changes. There are other beat down industry which could be possible to find stocks with promising prospects. Good luck!
Though if it reaches near rm4 again, I would at least have some money to average down for now LOL.
@Anxious, go download any bursa stock app and set specific price alerts. That way, you don't have to check the price so frequently if it doesn't move to a price that demands your attention.
Harta's QR should come out in another two to three weeks time. This week Shanghai is resuming production for several hundred companies. Unfortunately they will have to work and sleep in the same compound.
The previous QR for Dec 2021 (Q3) was released only on 2nd week of Feb, I'm expecting the Q4 to be released after Raya holiday, if not later.
However, personally I'm a little bearish for the price movement after said QR as it is basically a compilation of the first 3 quarters plus a 4th quarter inclusive of cukai makmur, having doubts if Q4 can significantly outperform expectation. But it is also not to the extent that I'm confident enough to sell now and buy back later. Hate to buy high sell low. Just ready bullet for reload to catch the drop, if any.
I think its too late for bag holders like us to consider selling now. Worst case scenario , it goes down to RM3.50 but I doubt it will stay there very long. So for me I will hold on to my shares and wait for it to rebound. Someday, it will stop falling.
Most of the Europe country request resume natural gas supply from Russia in private as they can afford country daily operation without normal natural gas supply, Russia plan to increase military force to invade Ukraine recently without negotiation, Beijing full lock down confirm, all news from China insider govement.
Since last year, after every Quarterly Results, the share price just keeps on dropping.
I read somewhere that the results will be out tomorrow. Hopefully we don't test the 52 week low of RM4.15 next month.
Really tired of this endless SP dropping every quarter for a company that even in January last year was receiving so much praise.
Luckily, I dont need the money and am content to receive the dividends until it bounces back.
Any idea how much the dividend could be? Hopefully at least 10 sen but it could even be 5 sen?
With the benefit of hindsight, I probably should have cut loss long ago but at these prices, I believe there is more upside to downside, so I am still hanging on.
Surely it cant go to ZERO right, although dividend could.
Hopefully the selling stops and the SP finds some support soon as its truly depressing to see the SP to continue to slide.
Having said all that, I am not holding my breath.....
Intco Medical 1Q2022 results: Revenue CNY2,288m Core net profit attributable to owners CNY93m EPS CNY0.15 Equity attributable to owners CNY15,958m
Based on above, 1Q22 net margin is 4% Based on today closing price at CNY35.6, assume EPS is maintained at current level, PE = 35.6/ (0.15*4) = 59 times Annualized ROE = 2.3%
大马四大手套生产商,哪一家最值得投资? TOP GLOVE CORPORATION BHD HARTALEGA HOLDINGS BHD SUPERMAX CORPORATION BHD KOSSAN RUBBER INDUSTRIES BHD https://youtu.be/z3F3HTLXTlo
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
apple168
6,236 posts
Posted by apple168 > 2022-04-01 19:48 | Report Abuse
Harta, you bring us fortune! Marvelous!